Toward objective cervical cancer screening: Maybe the eyes do have it

American Journal of Clinical Pathology

Volumn 134, Issue 1, 2010, Pages 5-6

  Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CYTOPATHOLOGY; EDITORIAL; HEALTH CARE QUALITY; HUMAN; IMMUNOCYTOCHEMISTRY; LABORATORY TEST; MEDICAL LITERATURE; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CANCER; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77954480813     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP6OORTVEZRK7Y     Document Type: Editorial

References (4)

1. Stoler MH. Toward objective quality assurance: the eyes don't have it [editorial]. Am J Clin Pathol. 2002;117:520-522.
2. Arbyn M, Ronco G, Meijer CJ, et al. Trials comparing cytology with human papillomavirus screening [letter]. Lancet Oncol. 2009;10:935-936.
3. INK4a cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL Pap cytology results. Am J Clin Pathol. 2010;134:12-21.
4. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355.